Tapan Mehta

Optimizing an extended care intervention to promote weight loss maintenance: Protocol for the OPT-X multiphase optimization strategy factorial trial

Gareth R. Dutton, Amber W. Kinsey, Rikki M. Tanner, Olivia Krantz et autres

BACKGROUND: Weight loss maintenance (WLM) remains a limitation of behavioral obesity interventions, as long-term adherence is burdensome and diminishes over time. Simplified recommendations and/or alternative delivery methods that target evidence-based WLM strategies may reduce burden to improve long-term outcomes. METHODS: This protocol …

us (code pays fourni par la source)

Challenges Implementing Remote Patient Monitoring for Hypertension

Tanjila Nawshin, Eric (Trombonist) Wallace, Tapan Mehta

us (code pays fourni par la source)

Essential Informatics Tools and Computing Infrastructure for Big Data to Advance Artificial Intelligence in Rheumatology

Jeffrey R. Curtis, Emily Holladay, Tapan Mehta, John D. Osborne

us (code pays fourni par la source)

The Tele-Exercise And Multiple Sclerosis (TEAMS) study: A non-inferiority trial of remote versus clinic-based exercise for people with MS in the Deep South

Salma Aly, Navneet Kaur Baidwan, Hui‐Ju Young, Tracy Flemming-Tracy et autres

us (code pays fourni par la source)

Use of Semaglutide and Tirzepatide in Rheumatic and Musculoskeletal Diseases: Insights on Initiation Patterns and Weight Loss From the Rheumatology Informatics System for Effectiveness Registry

Nicholas P. McCormick, Cristiano Soares de Moura, Jingyi Zhang, Emily E. Holladay et autres

OBJECTIVE: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) such as semaglutide (SEM) and tirzepatide (TZP) were initially approved for type 2 diabetes management but are increasingly used for weight loss. Limited data exist on real-world use among patients with rheumatic and musculoskeletal diseases …

us (code pays fourni par la source)